CLINICAL_TRIALS
trial_result
· 2024-06-14
Clinical Trial Update: A Phase I Study of XJ101 in Chinese Healthy Subjects [Phase 1]
Summary
A Phase 1 trial update for XJ101 conducted in Chinese healthy subjects; the listed condition is Staphylococcus aureus bloodstream infection.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Starmab biologics（Shanghai）Co,.ltd | Conditions: Staphylococcus Aureus Bloodstream Infection | Phase 1 | Status: UNKNOWN